Chinese Patent Office issued patent for Merck’s CRISPR technology used in a genomic-integration method for eukaryotic cells

Merck today (23 APR 2018) announced that the Chinese Patent Office has issued a notice granting Merck’s patent application for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells. Patent in China covers integration of an external … Read the full press release →